CAU
EXPO icon

Caxton Associates (UK)’s Exponent EXPO Stock Holding History

Caxton Associates (UK)’s Portfolio EXPO Stock Details EXPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
6,078
+2,734
+82% +$168K 0.01% 605
2026
Q1 		$218K Buy
+3,344
New +$238K ﹤0.01% 697
2025
Q3 		– Sell
-31,686
Closed -$2.37M – 786
2025
Q2 		$2.37M Buy
31,686
+23,866
+305% +$1.85M 0.06% 160
2025
Q1 		$634K Buy
+7,820
New +$681K 0.02% 425

Other funds holding EXPO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caxton Associates (UK)'s EXPO Position: Q2 2026 in Review

Caxton Associates (UK) increased its Exponent (EXPO) stake by 82% in Q2 2026, buying an estimated $168K and bringing the position to 6,078 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #605.

Caxton Associates (UK) first reported a position in EXPO in Q1 2025 and has held it in 4 quarters since. The position peaked at $2.37M in Q2 2025. 341 funds tracked by Wall St. Rank hold EXPO as of Q2 2026.

  • Caxton Associates (UK) held 6,078 shares of Exponent worth $357K as of Q2 2026.
  • Caxton Associates (UK) bought 2,734 Exponent shares in Q2 2026, an estimated $168K.
  • Exponent made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #605 holding.
  • Caxton Associates (UK) first reported a position in Exponent in Q1 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Exponent position peaked at $2.37M in Q2 2025.
  • 341 funds tracked by Wall St. Rank held Exponent as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.